Hopes are high for the first disease modifying treatments in Alzheimer’s disease to be approved on the European market, but many challenges remain. Quantify Research colleagues Anders Gustavsson and Lena Jacobs are co-authors of a study on the capacity constraints for diagnosing Alzheimer’s disease in Sweden.
More Alzheimer specialists are needed to reduce expected waiting times approaching 5 years for individuals who could benefit from treatment.
The full study is now published with open access, read it here!